Stock Quotes in this Article: CADX, SYRG, SUPN, MEIP, BDBD

MADISON, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

>>5 Hated Earnings Stocks That Deserve Your Love

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside today.

>>5 Stocks Poised to Break Out

Sunshine Heart

Sunshine Heart (SSH) is an early-stage medical device company focused on developing, manufacturing and commercializing its C-Pulse Heart Assist System for treatment of Class III and ambulatory Class IV heart failure. This stock closed up 6.2% to $5.45 on Tuesday.

Tuesday's Range: $5.39-$5.66

52-Week Range: $2.50-$17.25

Volume: 344,000

Three-Month Average Volume: 68,690

Shares of SSH trended higher Tuesday after the company reported in-line results of a net loss of 47 cents per share.

>>3 Biotech Stocks Surging on Big Volume

From a technical perspective, SSH gapped up sharply higher here right above some near-term support at $5 with above-average volume. This move is quickly pushing shares of SSH within range of triggering a near-term breakout trade. That trade will hit if SSH manages to take out its 50-day moving average of $5.70 with high volume.

Traders should now look for long-biased trades in SSH as long as it's trending above Tuesday's low of $5.37 and then once it sustains a move or close above $5.70 with volume that hits near or above 68,690 shares. If that breakout triggers soon, then SSH will set up to re-fill some its previous gap down zone from April that started near $6.25. Any high-volume move above $6.25 to $6.50 will then put its next major overhead resistance levels at its 200-day of $6.67 to $7 into range for shares of SSH.

Supernus Pharmaceuticals

Supernus Pharmaceuticals (SUPN) is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. This stock closed up 5.2% to $5.39 on Tuesday.

Tuesday's Range: $4.94-$5.44

52-Week Range: $4.30-$16.68

Volume: 1.53 million

Three-Month Average Volume: 381,992

Shares of SUPN ripped higher on Tuesday after the company beat Wall Street EPS estimates by 8 cents per share.

>>5 Rocket Stocks to Buy This Week

From a technical perspective, SUPN ripped higher here right above some near-term support at $4.85 with heavy upside volume. This move is quickly pushing shares of SUPN within range of triggering a major breakout trade. That trade will hit if SUPN manages to take out its 50-day at $5.64 and then once it clears more near-term resistance levels at $5.68 to $6.29 with high volume.

Traders should now look for long-biased trades in SUPN as long as it's trending above some key near-term support levels at $5 or $4.85 and then once it sustains a move or close above those breakout levels with volume that hits near or above 381,992 shares. If that breakout triggers soon, then SUPN will set up to re-test or possibly take out its next major overhead resistance levels at $7 to $8.

BG Medicine

BG Medicine (BGMD) is a life sciences company focused on the discovery, development and commercialization of novel diagnostic tests based on biomarkers for high-value market opportunities in healthcare. This stock closed up 3.5% to $1.73 on Tuesday.

Tuesday's Range: $1.65-$1.76

52-Week Range: $1.00-$7.10

Volume: 154,000

Three-Month Average Volume: 255,357

From a technical perspective, BGMD trended up here right above some near-term support levels at $1.60 to $1.56 with lighter-than-average volume. This stock has been trending sideways for the last month and change, with shares moving between $1.56 on the downside and around $2 on the upside. Shares of BGMD are now quickly moving within range of triggering a near-term breakout trade above the upper-end of its recent sideways trading chart pattern. That breakout will hit if BGMD manages to take out its 50-day at $1.76 and then once it clears more resistance levels at $1.84 to $2 with high volume.

Traders should now look for long-biased trades in BGMD as long as it's trending above some key near-term support levels at $1.60 to $1.56 and then once it sustains a move or close above those breakout levels with volume that hits near or above 255,357 shares. If that breakout triggers soon, then BGMD will set up to re-test or possibly take out its next major overhead resistance levels at $2.30 to $2.53. Any high-volume move above $2.53 will then put its 200-day at $2.69 to $3 into range for shares of BGMD.

Synergy Resources

Synergy Resources (SYRG) is an exploration stage company engaged in oil and gas acquisitions, exploration, development and production activities. This stock closed up 4.4% to $6.80 on Tuesday.

Tuesday's Range: $6.54-$6.80

52-Week Range: $2.40-$7.78

Volume: 130,000

Three-Month Average Volume: 254,095

From a technical perspective, SYRG bounced higher here right above some near-term support at $6.37 with lighter-than-average volume. This stock has been finding buying interest over the last month and change, each time it's pulled back near $6.20. Shares of SYRG are now quickly moving within range of triggering a near-term breakout trade. That trade will hit if SYRG manages to take out its 50-day at $6.85 and then once it clears some more near-term overhead resistance levels at $6.80 to $7 with high volume.

Traders should now look for long-biased trades in SYRG as long as it's trending above its 50-day at $6.84 or above some key near-term support at $6.37 and then once it sustains a move or close above those breakout levels with volume that hits near or above 254,095 shares. If that breakout triggers soon, then SYRG will set up to re-test or possibly take out its next major overhead resistance levels at $7.53 to $7.78. Any high-volume move above $7.78 will then push shares of SYRG into new 52-week high territory, which is bullish technical price action.

Accelerate Diagnostics

Accelerate Diagnostics (AXDX) develops BACcel system, planned for rapid diagnosis in life-threatening bacterial infections. It has also developed and out-licensed OptiChem surface coatings for use in microarraying components. This stock closed up 7.7% to $8.24 on Tuesday.

Tuesday's Range: $7.79-$8.50

52-Week Range: $2.25-$8.99

Volume: 81,000

Three-Month Average Volume: 66,121

From a technical perspective, AXDX soared higher here right above some near-term support at $7.50 with above-average volume. This stock has been uptrending strong for the last month, with shares soaring higher from its low of $4.80 to its intraday high of $8.50. During that uptrend, shares of AXDX have been consistently making higher lows and higher highs, which is bullish technical price action. That move is now quickly pushing shares of AXDX within range of triggering a major breakout trade. That trade will hit if AXDX manages to clear its 52-week high at $8.99 with high volume.

Traders should now look for long-biased trades in AXDX as long as it's trending above some key near-term support at $7.50 or $7.38 and then once it sustains a move or close above $8.99 with volume that hits near or above 66,121 shares. If that breakout triggers soon, then AXDX will set up to enter new 52-week high territory, which is bullish technical price action. Some possible upside targets off that breakout are $10 to $12.

Cadence Pharmaceuticals

Cadence Pharmaceuticals (CADX) is a biopharmaceutical company focused on in-licensing, developing and commercializing product candidates mainly for use in the hospital setting. This stock closed up 5% to $7.10 on Tuesday.

Tuesday's Range: $6.73-$7.16

52-Week Range: $2.56-$7.45

Volume: 847,000

Three-Month Average Volume: 293,838

From a technical perspective, CADX ripped higher here right above its 50-day moving average at $6.39 with heavy upside volume. This move is quickly pushing shares of CADX within range of triggering a major breakout trade. That trade will hit if CADX manages to take out some near-term overhead resistance levels at $7.20 to its 52-week high at $7.45 and then once it clears some past resistance at $7.78 with high volume.

Traders should now look for long-biased trades in CADX as long as it's trending above some key near-term support levels at $6.47 to its 50-day at $6.39 and then once it sustains a move or close above those breakout levels with volume that hits near or above 293,838 shares. If that breakout triggers soon, then CADX will set up to enter new 52-week high territory, which is bullish technical price action. Some possible upside targets off that breakout are $9.50 to $10.

Boulder Brands

Boulder Brands (BDBD) is a marketer of functional food products under the Smart Balance, Earth Balance and Bestlife trademarks. This stock closed up 2.5% to $9.85 on Tuesday.

Tuesday's Range: $9.60-$9.95

52-Week Range: $5.56-$13.99

Volume: 469,000

Three-Month Average Volume: 1.04 million

From a technical perspective, BDBD bounced modestly higher here right off some near-term support at $9.50 with lighter-than-average volume. This stock has been uptrending for the last month and change, with shares pushing higher from its low of $8.16 to its recent high of $9.99. During that move, shares of BDBD have been mostly making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of BDBD within range of triggering a major breakout trade. That trade will hit BDBD manages to take out some near-term overhead resistance levels at $9.80 to $9.99 with high volume.

Traders should now look for long-biased trades in BDBD as long as it's trending above some key near-term support at $9.50 or above its 50-day at $9.02 and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.04 million shares. If that breakout hits soon, then BDBD will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day moving average of $11.29 to $12, or even $13.

MEI Pharma

MEI Pharma (MEIP) is developing cancer therapeutics based on the central design of naturally occurring compounds called isoflavones. This stock closed up 3.5% to $9.24 on Tuesday.

Tuesday's Range: $8.87-$9.30

52-Week Range: $1.98-$13.20

Volume: 56,000

Three-Month Average Volume: 94,413

From a technical perspective, MEIP bounced higher here right above its 50-day moving average of $8.46 with lighter-than-average volume. This stock has been trending sideways in a tight consolidation pattern for the last two months, with shares moving between $7.29 on the downside and $9.65 on the upside. Shares of MEIP are now finding support at its 50-day and it's quickly moving within range of triggering a major breakout. That breakout will hit if MEIP manages to take out some key near-term overhead resistance levels at $9.50 to $9.65 with high volume.

Traders should now look for long-biased trades in MEIP as long as it's trending above its 50-day at $8.46 or above some near-term support at $8 and then once it sustains a move or close above those breakout levels with volume that hits near or above 94,413 shares. If that breakout hits soon, then MEIP will set up to re-test or possibly take out its next major overhead resistance levels at $12 to $13.18. Any high-volume move above $13.18 will then put $15 into range for shares of MEIP.

To see more stocks that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Madison, Wis.

RELATED LINKS:

>>5 Toxic Stocks to Sell in May and Go Away
>>4 GARP Growers to Buy This Summer

>>4 Stocks Looking to Break Out

Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Madison, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.